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Abstract Recent lineage tracing analyses have significantly improved our understanding of
immune system development and highlighted the importance of the different hematopoietic
waves. The current challenge is to understand whether these waves interact and whether this
affects the function of the immune system. Here we report a molecular pathway regulating the
immune response and involving the communication between embryonic and larval hematopoietic
waves in Drosophila. Down-regulating the transcription factor Gcm specific to embryonic
hematopoiesis enhances the larval phenotypes induced by over-expressing the pro-inflammatory
Jak/Stat pathway or by wasp infestation. Gcm works by modulating the transduction of the Upd
cytokines to the site of larval hematopoiesis and hence the response to chronic (Jak/Stat over-
expression) and acute (wasp infestation) immune challenges. Thus, homeostatic interactions control
the function of the immune system in physiology and pathology. Our data also indicate that a
transiently expressed developmental pathway has a long-lasting effect on the immune response.
DOI: https://doi.org/10.7554/eLife.34890.001
Introduction
In vertebrates, immune cells are generated from hematopoietic waves occurring at distinct places
and times. The first wave occurs in the yolk sac and generates primitive erythrocytes and macro-
phages (Baron et al., 2012; Perdiguero and Geissmann, 2016). Later waves occur at several time
points from embryonic to adult stages and produce all the blood lineages of the adult organism
(Cumano and Godin, 2007; Orkin and Zon, 2008). Recent advances in lineage tracing approaches
have made it possible to unambiguously assess the origin of immune cells and have shown that the
immune cells from distinct hematopoietic waves coexist (Perdiguero and Geissmann, 2016;
Ginhoux et al., 2010; Gomez Perdiguero et al., 2015; Hoeffel et al., 2015; Ghosh et al., 2015).
Despite these great advances, however, the precise contribution of each wave to the immune
response is still poorly understood (Ditadi et al., 2017). Moreover, cells from the early wave could
help those from later mounting an appropriate response, calling for homeostatic interactions in
physiological and pathological conditions.
In Drosophila melanogaster and Manduca sexta, a first hematopoietic wave occurs in the proce-
phalic mesoderm during the embryonic life (Nardi et al., 2003; Gold and Bru¨ckner, 2014). Pluripo-
tent precursors called prohemocytes generate plasmatocytes and crystal cells that constitute the
only immune cells until the larval stage. The crystal cells represent 5% of the hemocytes, they remain
close to the proventriculus and play role in melanization; the plasmatocytes represent 95% of the
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hemocytes and are professional macrophages that populate the whole animal. During the larval life,
the plasmatocytes shuttle between the hemolymph (circulating hemocytes) and a subepithelium
compartment they transiently attach to (resident or sessile hemocytes) (Gold and Bru¨ckner, 2014;
Stofanko et al., 2008). The second wave occurs at the larval stage in the lymph gland (Nardi et al.,
2003; Grigorian and Hartenstein, 2013), which starts forming during embryogenesis and keeps
growing until the onset of metamorphosis, when it disintegrates to release plasmatocytes and crystal
cells into the organism. Upon an acute challenge such as wasp infestation, the larva mounts a com-
plex immune response and similar phenotypes are observed in genetic backgrounds in which pro-
inflammatory pathways such as Jak/Stat are constitutively activated, a condition that could be con-
sidered as analogous to chronic inflammation (Luo et al., 1995; Harrison et al., 1995). Typically, the
resident hemocytes leave the sessile compartment and enter in circulation, hemocytes proliferate
and plasmatocytes transform into lamellocytes to form cell aggregates called ‘melanotic tumors’
that encapsulate the parasite wasp egg, the lymph gland undergoes premature histolysis and hemo-
cyte release (Letourneau et al., 2016). The sequence of these events and the contribution of embry-
onic hematopoiesis to this immune response are not clear.
We here describe a link in the regulation of inflammation and its threshold of response between
events that, in the past, have been described as independent events separated in time and location.
We show that the embryonic wave is necessary to mount an adequate immune response upon sig-
naling to the larval wave and that the only known transcription factor specific of the embryonic
hemocytes, Glide/Gcm (Gcm throughout the manuscript) (Bernardoni et al., 1997; Lebestky et al.,
2000; Alfonso and Jones, 2002; Bataille´ et al., 2005; Avet-Rochex et al., 2010) is a major player
in this process. Gcm induces the expression of Jak/Stat inhibitors and in so doing inhibits the pro-
duction of Jak/Stat dependent pro-inflammatory cytokines that eventually control the Jak/Stat path-
way in the muscle. As a consequence, the second hematopoietic wave occurring in the lymph gland
is affected as well. Thus, the embryonic hematopoietic wave contributes to the inflammatory
response and modulates larval hematopoiesis, demonstrating the importance of interactions
between embryonic hemocytes and the lymph gland during the inflammatory response. Finally, we
highlight the long-lasting effect of a transcription factor expressed early and transiently during
hematopoiesis.
Results
Gcm inhibits melanotic tumor formation and induces the expression of
jak/Stat inhibitors
Our first step was to investigate the impact of the embryonic plasmatocytes on systemic inflamma-
tion. The Jak/Stat pathway is a major transducer of the inflammatory signal upon immune challenge.
Its constitutive activation due to the mutation hopscotchTum-l (hopTum-l) (Luo et al., 1995) in the Jak
kinase induces the formation of melanotic tumors in larvae, a strong increase in the number of hemo-
cytes, the production of lamellocytes (Figure 1a–e) and precocious lymph gland histolysis
(Luo et al., 1995; Harrison et al., 1995). We crossed hopTum-l flies with flies in which we modulated
the expression of the Gcm transcription factor. Gcm is expressed early and transiently in the first
hematopoietic wave, from embryonic stage 5 to stage 11, but no longer in the mature plasmato-
cytes (Bernardoni et al., 1997; Alfonso and Jones, 2002; Evans et al., 2003), nor is it expressed
during the larval hematopoietic wave (Figure 1—figure supplement 1) (Bernardoni et al., 1997;
Lebestky et al., 2000; Alfonso and Jones, 2002; Bataille´ et al., 2005; Avet-Rochex et al., 2010;
Zaidman-Re´my et al., 2012). Homozygous gcm null embryos die before hatching and show a
slightly reduced number of plasmatocytes (Bataille´ et al., 2005) with concomitant increase in crystal
cell number (Bataille´ et al., 2005) (Figure 1—figure supplement 2a–e), however downregulating
Gcm expression with the UAS-gcmRNAi transgenic line (crossed with the gcmGal4 or gcm> line
(gcm> gcm KD) (Gupta et al., 2016) (Figure 1—figure supplement 3a,b) induces a milder pheno-
type: the animals are viable, the number of hemocytes and that of crystal cells is similar to that of
control animals (Figure 1d, Figure 1—figure supplement 3c–h). Interestingly, gcm KD larvae con-
tain no melanotic tumors and very rare lamellocytes (Figure 1b,d, Figure 1—figure supplement 4a–
c’). Accordingly, gcm KD hemocytes express most plasmatocyte and few lamellocyte markers
(Figure 1f).
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Figure 1. Gcm hinders Jak/Stat-mediated melanotic tumor formation. (a) Third instar larvae of the indicated
genotypes (Note that all the detailed genotypes are in the Supplementary Methods, Fly strains and genetics
section). White arrowheads indicate the melanotic tumors. (b) Penetrance of melanotic tumors (50). (c) Phenotype
expressivity assessed as tumor size (n > 40). (d) Total number of circulating hemocytes and lamellocyte
contribution (n = 3, using 10 larvae/replicate). (e) Hemocytes (red) and tumors (black) in third instar larvae of the
mentioned genotypes. Assessment in terms of tumor penetrance, size and number of tumors/larva, number of
circulating hemocytes and percentage of lamellocytes (n = 3, using 10 larvae/replicate). In all figures, *p<0.00.5,
**p<0.01; ***p<0.001, ns: not significant; scale bar: 50 mm unless otherwise specified. All the P values shown in this
and in the following figures are in Figure 1—source data 1. (f) Relative expression levels of plasmatocyte and
lamellocyte markers in larval hemocytes gcm> gcm KD compared to gcm> , measured by qPCR. The data are
Figure 1 continued on next page
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Combining gcm KD with hopTum-l triggers much more severe defects than those shown by hop-
Tum-l animals: the penetrance of the tumors increases from 36% to 85% (% of larvae carrying the
tumors, Figure 1b,e), the tumors are bigger (Figure 1c,e, Figure 1—figure supplement 4d) and
the larvae produce more lamellocytes (Figure 1d,e). In addition, animals in which the Jak/Stat path-
way is constantly active and express Gcm at low levels have reduced viability, with fewer larvae
hatching as compared to control animals (i.e. animals that only express one of the two molecular
defects). An exacerbated tumor phenotype is also observed upon crossing gcm KD flies with a
gcmGal4 driver inactive in glia (repoGal80,gcm> or gcm(hemo)> ), the other main territory of Gcm
expression, or with independent embryonic-specific hemocyte drivers (srp(hemo)> and sn> ) or upon
using the gcm26 null mutation in heterozygous conditions (Figure 1—figure supplement 4e). Thus,
the expression of the Gcm transcription factor in the primitive hemocytes modulates the inflamma-
tory response induced by the constitutive activation of the Jak/Stat pathway. Gcm plays an impor-
tant role as its over-expression (gcm Gain of Function or GOF) rescues the hopTum-l phenotype as
well as that of hopTum-l;gcm KD animals (Figure 1b). Interestingly, the number of circulating hemo-
cytes is 5.5-fold higher in hopTum-l compared to wild-type animals, but the further increase observed
in hopTum-l;gcm KD animals is incremental (1.1-fold), mostly due to an increase of lamellocytes’ num-
ber (Figure 1d,e).
The hemocyte phenotype predicts that Gcm inhibits the Jak/Stat pathway. Since the activation of
the pathway leads to the phosphorylation and to the nuclear translocation of the Stat transcription
factor, we first transfected S2 Drosophila cells with a Gcm and/or with a HopTum-l expression vector
and validated this prediction in vitro. Gcm represses the nuclear localization of Stat induced by hop-
Tum-l (Figure 2a–c’’’, Figure 1—figure supplement 4f). Next, we investigated the molecular mecha-
nisms by which Gcm could affect inflammatory response. A genome-wide DamID screen identifying
the direct targets of Gcm highlighted several negative regulators of that pathway (Cattenoz et al.,
2016) and we selected three major Jak/Stat inhibitors based on their role in hematopoiesis: Ptp61F,
Socs36E and Socs44A (Mu¨ller et al., 2005) (Figure 2d, Figure 1—figure supplement 4g–i). Ptp61F
acts by de-phosphorylating Hop, the only Jak present in flies, and the transcription factor Stat92E
(Mu¨ller et al., 2005; Baeg et al., 2005; Villarino et al., 2017). Socs36E and Socs44A belong to the
suppressor of cytokine signaling family that suppresses Jak/Stat activation by competing with Stat
for binding to the Jak catalytic domain (Naka et al., 1997; Yasukawa et al., 1999). Transfecting S2
Drosophila cells with a Gcm expression vector increases the endogenous levels of Ptp61F, Socs36E
and Socs44A transcripts (Figure 2e). In addition, gcm KD embryos express these genes at low levels,
validating Gcm as a regulator of the three genes, likely at the transcriptional level (Figure 2f).
Since Gcm is specifically expressed in the embryonic hemocytes, we assessed whether inhibiting
the Jak/Stat pathway only in those cells affects the immune response. hopTum-l animals in which the
expression of any of the three inhibitors is specifically silenced in embryonic hemocytes (gcm> )
show a strong enhancement of the tumor penetrance (> 90%, Figure 2g). Accordingly, the over-
expression of Ptp61F in embryonic hemocytes rescues the hopTum-l phenotype and the exacerbated
phenotype observed in the hopTum-l/+;gcm KD larvae (Figure 2g).
Figure 1 continued
normalized to two housekeeping genes and then the ratio (gcm> gcm KD/gcm) is plotted (n = 4). The error bars
represent the sum of the s.e.m. of gcm> gcm KD and gcm> .
DOI: https://doi.org/10.7554/eLife.34890.002
The following source data and figure supplements are available for figure 1:
Source data 1. p-values for all figures.
DOI: https://doi.org/10.7554/eLife.34890.007
Figure supplement 1. Gcm is not expressed in the second hematopoietic wave.
DOI: https://doi.org/10.7554/eLife.34890.003
Figure supplement 2. Crystal cell phenotype in gcm26 embryos.
DOI: https://doi.org/10.7554/eLife.34890.004
Figure supplement 3. Crystal cell phenotype in gcm KD larvae.
DOI: https://doi.org/10.7554/eLife.34890.005
Figure supplement 4. Gcm inhibits Jak/Stat-mediated melanotic tumor formation.
DOI: https://doi.org/10.7554/eLife.34890.006
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Figure 2. Gcm induces the expression of Jak/Stat inhibitors and hinders Jak/Stat-mediated melanotic tumor
formation. (a–c) Immunolabelling of S2 cells transfected with pPac-gal4 and pUAS-RFP (Control, (a), or pPac-gal4,
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expression levels of Jak/Stat downstream targets (apt (Starz-Gaiano et al., 2008), CG1572 (Bina et al., 2010),
CG13559 (Bina et al., 2010), Galphaf (Ga73b) (Bina et al., 2010; Bausek and Zeidler, 2014) and slbo [Silver and
Montell, 2001]) in hemocytes from stage 16 embryo srp(hemo)> gcm GOF. The data are relative to the levels in
controls as described in Figure 1f.
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To assess the impact of Gcm on the Jak/Stat pathway, we analyzed the levels of expression of
down-stream targets of Stat92E upon gcm GOF in hemocytes from stage 16 embryos. Several tar-
gets of Stat92E were previously described in S2 cells and in hemocytes: apt (Starz-Gaiano et al.,
2008), CG1572 (Bina et al., 2010), CG13559 (Bina et al., 2010), Galphaf (Ga73b) (Bina et al.,
2010; Bausek and Zeidler, 2014) and slbo (Silver and Montell, 2001). The over-expression of Gcm
significantly reduces the levels of expression of these genes (Figure 2h), suggesting that Gcm inhib-
its the Jak/Stat pathway upon inducing the expression of the inhibitors Ptp61F, Socs36E and
Socs44A.
Finally, and most strikingly, Gcm affects the Jak/Stat-mediated lymph gland phenotype (Figure 3).
The penetrance of lymph glands histolyzed at wandering L3 and the presence of lamellocytes (L4
marker in green) observed in hopTum-l/+larvae are rescued in hopTum-l/+larvae in which Gcm is over-
expressed (hopTum-l/+;gcm GOF), while they are enhanced in hopTum-l/+;gcm KD larvae. Because the
penetrance of the hopTum-l/+phenotype is already high in Wandering L3 (~112 hr after egg laying
(hAEL)), we hypothesized that down-regulating Gcm might induce a stronger defect at an earlier
stage. The difference in lymph gland histolysis between hopTum-l/+and in hopTum-l/+;gcm KD larvae
is indeed much more significant in Late L3 larvae (~96 hAEL): 46.7% hopTum-l/+larvae and 80.0% hop-
Tum-l/+;gcm KD larvae display lymph gland histolysis (Figure 3g–k). Thus, silencing Gcm accelerates
the lymph gland defects, highlighting the interaction between the two hematopoietic waves and
revealing the embryonic transcription factor Gcm as an important player in the process.
In sum, Gcm subverts the inflammatory response due to constitutive activation of Jak/Stat by
inducing the expression of inhibitors of this pathway.
Gcm regulates signaling from the embryonic to the larval
hematopoietic wave
We then asked how the embryonic hemocytes signal to the lymph gland. Prime candidates are the
pro-inflammatory cytokines of the Upd family since their expression is induced in cells of both
hematopoietic waves by wasp infestation (11-fold for Upd2 and 38-fold for Upd3 [Yang et al.,
2015]) or by septic injury (Yang et al., 2015; Agaisse et al., 2003) and their mutations prevent the
encapsulation of the wasp egg by the fly hemocytes (Makki et al., 2010).
hopTum-l animals that are heterozygous for upd2 and upd3 display a reduced penetrance of the
melanotic tumor phenotype (Figure 4—figure supplement 1a). Moreover, specific Upd2 or Upd3
over-expression in the embryonic hemocytes (gcm> upd2 GOF or upd3 GOF) is sufficient to induce
lymph gland precocious histolysis as well as melanotic tumor formation (Figure 4a,d). Thus, cytokine
expression solely in the embryonic hemocytes is sufficient to trigger an inflammatory response.
Accordingly, conditional down-regulation of upd2 or upd3 (gcm> upd2 or upd3 KD) in hopTum-l res-
cues the lymph gland phenotypes induced by the hopTum-l mutation (precocious histolysis and pres-
ence of lamellocytes, Figure 4a–c).
We next asked whether the inhibitory role of Gcm on the Jak/Stat pathway involves Upd2 and/or
Upd3. Gcm inhibits the expression of upd2 and upd3, as their transcript levels increase upon silenc-
ing Gcm in hemocytes (Figure 4e–f). In addition, transfecting a Gcm expression vector lowers the
expression of the two cytokines in S2 cells (Figure 4g). Most importantly, Upd2 and Upd3 are epi-
static to Gcm in vivo since down-regulating their expression in hopTum-l and even in hopTum-l/+;
gcm> gcm KD animals almost abolishes the formation of tumors (Figure 4h). Thus, Gcm suppresses
the production of pro-inflammatory cytokines in the embryonic hemocytes.
Of note, the tumor phenotype is induced by Upd2 or Upd3 over-expression but not by Gcm
silencing, suggesting that threshold levels of the inflammatory pathway may be required for the mel-
anotic tumors to form. Accordingly, the number of circulating hemocytes is higher in larvae over-
expressing Upd2 or Upd3 compared to those observed in gcm KD animals (Figure 4—figure sup-
plement 1e), and so are the levels of the cytokine transcripts (Figure 4e–f in the larvae; Figure 4—
figure supplement 1b,b’ in the embryos). Finally, silencing Gcm in animals that over-express either
cytokine has a moderate effect on the number of circulating hemocytes, further supporting the view
that Gcm does not act as an anti-proliferative factor (Figure 4—figure supplement 1e).
Next, we asked how Gcm, Upd2 and Upd3 are connected. Since Upds are the ligands of the Jak/
Stat pathway, which is inhibited by Gcm, we hypothesized that their expression also depends on
Jak/Stat signaling. Transfecting S2 cells with the HopTum-l expression vector strongly induces the
expression of upd2 and upd3 (Figure 4g) and these two loci contain STAT binding sites (Figure 4—
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figure supplement 1c,d), calling for a direct role of the Jak/Stat pathway in inducing the expression
of these two pro-inflammatory cytokines.
To summarize, Gcm suppresses the Jak/Stat pathway in the primitive wave, thus reducing expres-
sion of cytokines Upd2 and Upd3 that can act non-autonomously and signal to the lymph gland.
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Figure 4. Embryonic hemocytes signal through Upd2 and Upd3. (a) Lymph gland phenotypes. (b,c) Lymph gland
immunolabelling as in Figure 3c–f. (d) Tumor penetrance. (e–f) Relative expression levels of upd2 and upd3 in
Figure 4 continued on next page
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Jak/Stat activation in the embryonic hemocytes triggers melanotic
tumor and lymph gland phenotypes
Based on the above results, we hypothesized that the constitutive activation of the Jak/Stat pathway
within the first hematopoietic wave is sufficient to trigger tumor formation/lymph gland defects.
Indeed, larvae carrying the UAS-hopTum-l transgene and drivers specific to the embryonic hemocytes
display tumors, abnormal hematopoiesis and precocious lymph gland histolysis (Figure 5a–c third
column, Figure 5—figure supplement 1a–f). Moreover, silencing the Gcm target and Jak/Stat inhib-
itor Ptp61F in the embryonic hemocytes also triggers tumor formation (3.1% of tumors are detected
in gcm> Ptp61F KD, n = 128 compared to wild type 0%, n = 182, Khi2 p=0.0164).
Following this, we assessed whether activating the Jak/Stat pathway systemically or only in the
embryonic hemocytes (which we will refer to as conditional activation, for the sake of simplicity) pro-
duce comparable responses. The penetrance of the tumors is similar (Figure 5a third and fourth col-
umns), however, the overall phenotype is stronger in larvae that express hopTum-l systemically than in
larvae that express hopTum-l conditionally: the tumors are more numerous and larger, moreover,
88.8% of the lymph glands are histolyzed and contain lamellocytes (vs. 28% in UAS-hopTum-l lymph
glands, which contain no lamellocytes) (Figure 5a,b third and fourth columns).
To further characterize the role of Jak/Stat activation during the first wave, we analyzed both resi-
dent and circulating hemocyte populations. Their total numbers are significantly higher upon sys-
temic Jak/Stat activation (7214 hemocytes in systemic hopTum-l, 5689 hemocytes in conditional
hopTum-l, p=0.0002, Figure 5c third and fourth columns) and the number of dividing cells tends to
be higher as well (14.8% vs. 5.1% upon conditional activation, p=0.178, Figure 5—figure supple-
ment 1c). Finally, we analyzed the resident and the circulating populations separately, as the inflam-
matory response is known to trigger hemocyte mobilization from the sessile compartment
(Ma´rkus et al., 2009; Zettervall et al., 2004). Conditional and systemic activation of the Jak/Stat
pathway induce lamellocyte markers in hemocytes in both compartments (Figure 5—figure supple-
ment 1d–f). However, with the systemic mutation, we observe a depletion of hemocytes from the
resident compartment and an increase of the hemocytes in circulation (Figure 5c third and fourth
column), which indicates abnormal mobilization (Ma´rkus et al., 2009; Zettervall et al., 2004). This
does not occur upon Jak/Stat conditional activation in the embryonic hemocytes (Figure 5c third col-
umn). In addition, the percentage of resident lamellocytes and the rate of proliferation tend to be
higher upon systemic activation (Figure 5—figure supplement 1c,f).
In sum, systemic Jak/Stat activation affects the resident compartment more than conditional acti-
vation (fewer cells, mostly lamellocytes), likely due to the contribution of the Jak/Stat pathway in
additional tissues. Jak/Stat activation in the somatic muscles, which is known to control the inflam-
matory response upon wasp infestation (Yang et al., 2015), does not seem to account for the differ-
ent phenotypes observed in the sessile compartment as conditional HopTum-l expression also
activates the Jak/Stat pathway in the somatic muscles, as does systemic activation (measured by the
10xStat92E-GFP reporter, Figure 5—figure supplement 1g–i). In line with this, conditional HopTum-l
expression triggers increased levels of the protein accompanied by discrete accumulation in the
muscle nuclei (Figure 6a–b’, d). As predicted, these animals display high levels of expression of the
cytokines Upd2/3 in the hemocytes (Figure 5—figure supplement 1j,k) (Yang et al., 2015).
Figure 4 continued
hemocytes from wandering L3 larvae of the mentioned genotypes. upd2 and upd3 expression levels increase in
gcmgcm KD (e), first two columns from the left in e) and even further in gcm> upd2/3 GOF third instar larval
hemocytes (e’), column three in (f). Note the different scale between (e) and (e’). (g) upd2 and upd3 expression
levels in S2 cells upon transfection with pPac-gcm or pUAS-hopTum-l expression vectors, compared to control
levels shown by the dashed line (transfection of an empty expression vector) (n > 5). (h) Tumor penetrance in third
instar female larvae. (i) Schematic representation of Gcm contribution to Upd2 and Upd3 production from
embryonic hemocytes.
DOI: https://doi.org/10.7554/eLife.34890.010
The following figure supplement is available for figure 4:
Figure supplement 1. Interaction between Jak/Stat pathway, Gcm and Upd2/Upd3 cytokines.
DOI: https://doi.org/10.7554/eLife.34890.011
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Gcm inhibits the melanotic tumors induced by HopTum-l expression in
embryonic hemocytes
Since Jak/Stat activation in the embryonic hemocytes triggers defects in the immune system, the
phenotypes, we asked whether silencing Gcm aggravates those defects.
Similar to what observed for hopTum-l; gcm KD animals (Figures 1 and 3), reducing Gcm expres-
sion in gcm> hopTum-l animals enhances the phenotype induced by conditional Jak/Stat activation,
making it more similar to that triggered by systemic Jak/Stat activation (Figure 5 fourth column, Fig-
ure 5—figure supplement 1b–f). The tumor penetrance and expressivity increase and the lymph
glands are always precociously histolyzed in conditional hopTum-l;gcm KD animals (Figure 5b fourth
column). These phenotypes are not associated with an increase in hemocyte proliferation but with
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Figure 5. Inflammatory response upon systemic and conditional Jak/Stat activation. (a) Tumor penetrance,
phenotype expressivity assessed as number of tumors/larva and tumor size of control animals (gcm> ), systemic
hopTum-l, conditional hopTum-l (gcm> UAS-hopTum-l) and conditional hopTum-l,gcm KD (gcm(hemo)> gcm KD,UAS-
hopTum-l). The distribution of the tumor size is detailed in Figure 5—figure supplement 1b. (b) Precocious lymph
gland histolysis and lamellocyte labelling, note the 100% histolysis in conditional hopTum-l,gcm KD. (c) Total
number of hemocytes (circulating +sessile), number of circulating hemocytes and number of sessile hemocytes in
systemic and conditional hopTum-l mutations as compared to controls. n = 3, the numbers in gray indicate s.e.m.
DOI: https://doi.org/10.7554/eLife.34890.012
The following figure supplement is available for figure 5:
Figure supplement 1. Phenotypes induced by conditional activation of the Jak/Stat pathway in the embryonic
hemocytes.
DOI: https://doi.org/10.7554/eLife.34890.013
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Figure 6. Jak/Stat activation in the embryonic hemocytes activates the Jak/Stat pathway in Wandering L3 muscles.
(a–c) Muscle immunolabelling in Wandering larvae of the indicated genotypes. The Phalloidin labelling (in green)
highlights the striated muscle fibers rich in actin filament, Stat92E is in red and DAPI in blue. (a,b,c) show the
merge of the three channels, (a’,b’,c’) show Stat92E alone. Scale bar: 50 mm. Arrowheads indicate nuclei in the
muscles. (d,e) Box-plots representing the distribution of Stat92E intensity (d) and the ratio nuclear/cytoplasmic
Stat92E (e) in Wandering L3 muscles of the indicated genotypes. Stat92E intensity was quantified in more than 20
muscles in three animals and the ratio nuclear/cytoplasmic Stat92E was measured in more than 30 nuclei in three
animals for each genotype. From bottom to top, the boxes represent the 5% percentile, the first quartile, the
median, the third quartile and the 95% percentile. P-values were measured using student test after variance
analysis.
DOI: https://doi.org/10.7554/eLife.34890.014
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enhanced mobilization from the resident compartment (+411 hemocytes in circulation) (Figure 5c
fourth column). This latter feature is in line with the larger size of the tumors and with the finding
that gcm KD hemocytes show lower expression of eater (Figure 1f), a gene required for the attach-
ment of hemocytes to the sessile compartment (Anderl et al., 2016). Thus, knocking down gcm
affects hemocyte mobilization as does systemic Jak/Stat activation. Finally, combining the condi-
tional activation of the Jak/Stat pathway and gcm KD further enhances the levels of Stat92E in the
muscles and its nuclear localization (Figure 6b–e),
In sum, Jak/Stat activation in the first hematopoietic wave triggers an inflammatory response and
this response is enhanced in gcm KD animals.
Gcm controls the inflammatory response induced by wasp infestation
We next asked whether Gcm modulates the response to infestation by the wasp L. boulardi, which
constitutes a more physiological challenge as compared to the chronic challenge induced by a
genetically mutant background. Since the immune response to wasp infestation is highly dependent
to the conditions applied (Letourneau et al., 2016), we first established infestation parameters that
trigger comparable fly responses (see Materials and methods section). Our experimental design was
adjusted empirically to maximize the number of Drosophila larvae containing only one wasp egg.
Following this, we assessed the impact of Gcm on the overall immune response induced by wasp
infestation by analyzing wasp egg encapsulation in gcm KD condition. Similar to what we found with
hopTum-l, Gcm has an anti-inflammatory potential. gcm KD mutant larvae show a higher rate of wasp
egg encapsulation compared to control larvae, hence allowing fewer wasp eggs to develop. More-
over, fewer adult wasps hatch from gcm KD mutant larvae (Figure 7a,b). Thus, gcm KD animals
mount an exacerbated response to an acute challenge.
Since Gcm is no longer expressed by the time of infestation (nor is its expression induced by
infestation or by Jak/Stat activation, Figure 8—figure supplement 1), this developmental transcrip-
tion factor likely has priming and long-lasting effects on the embryonic hemocytes. To test this
hypothesis, we compared the levels of expression of several sets of genes in gcm mutant embryonic
and larval hemocytes (Figure 8). The levels of the plasmatocyte marker eater start decreasing in the
mutant embryos and are only significantly low in the larval stage. Similarly, the levels of the lamello-
cyte markers bint-v and PPO3 are only significantly high in the larva. Also, embryonic mutant hemo-
cytes show a decrease in the levels of the Ptp61F Jak/Stat inhibitor and direct target of Gcm
(Figure 2d–f, Figure 1—figure supplement 4h) and this effect is lost at the larval stage, in line with
the embryo-specific expression of Gcm (Figure 8). This decrease seems sufficient to enhance the
expression of the cytokines upd2 and upd3 in embryonic stage, which persists in the larval stage
(Figure 8). The initial effects observed in the embryo become more evident in the larva, likely
through positive feedback loops. To eliminate the possibility that we underestimate the embryonic
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Figure 7. The inflammatory response upon wasp infestation is exacerbated in gcm KD animals. (a) Histogram
representing the percentage of total, partial and no wasp egg encapsulation (n > 30). (b) Lethality of the parasitic
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phenotype due to latency in the RNAi induced defects, we specifically analyzed gcm null embryos.
Overall, these data suggest that Gcm modulates the level of activation of the Jak/Stat pathway at
embryonic stage, which primes hemocytes into a state that is highly sensitive to inflammatory signals
in the larval stage.
Timeline of events triggered by wasp infestation
The above findings strongly suggest that the embryonic hemocytes may represent an early, perhaps
the earliest cellular target of wasp infestation. To clarify this issue, we analyzed the timeline of three
cellular processes that accompany the response to wasp infestation (Figure 9a): the mobilization of
the resident hemocytes, the appearance of circulating hemocytes of larval origin, including the
appearance of lamellocytes, the formation of melanotic tumors.
At first, we followed the dynamic behavior of the hemocytes after embryogenesis using the
HmlDRFP (Makhijani et al., 2011) line. In physiological conditions, the hemocytes present in the 1st
larval stage do not display a stereotyped arrangement (Figure 9b). Hemocytes start homing and
localizing sub-epidermally by L2. The so-called sessile pockets become evident by Early L3 and the
process continues until Late L3, when the population of resident hemocytes becomes very prominent
and stereotyped. Upon wasp infestation, the resident compartments are already disrupted by Early
L3 (30 hr after infestation), with many hemocytes being in circulation (Figure 9c,d). We quantified
the phenotypes and counted in average 7.4 sessile pockets/larva (s.e.m. 0.27) in control and 1.2
pockets (s.e.m. 0.31) in infested animals. Thus, hemocyte mobilization is a very early event.
We next traced the hemocyte lineage within the tumors (gcm> gtrace LacZ animals after wasp
infestation) and labelled them with the Serpent antibody. In our conditions, the tumors start appear-
ing by Late L3 and seem to mostly contain hemocytes of embryonic origin (Srp positive, LacZ
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Figure 8. Gcm impacts the development and the inflammatory response of hemocytes. Relative expression levels
of plasmatocyte and lamellocyte markers, Jak/Stat inhibitor and cytokines in hemocytes from stage 16 mutant
embryos (srp(hemo)> RFP,gcm [Cattenoz et al., 2016]) or from third instar mutant larvae (gcm> gcm KD). The
levels represented are relative to the levels in controls (srp(hemo)> RFP for the embryos and gcm> for the larvae)
after normalization against housekeeping genes. The data are displayed as described in Figure 1f.
DOI: https://doi.org/10.7554/eLife.34890.016
The following figure supplement is available for figure 8:
Figure supplement 1. Gcm is not induced in circulating hemocytes nor in lymph glands of 3rd instar larvae upon
wasp infestation.
DOI: https://doi.org/10.7554/eLife.34890.017
Bazzi et al. eLife 2018;7:e34890. DOI: https://doi.org/10.7554/eLife.34890 13 of 30
Research article Developmental Biology Stem Cells and Regenerative Medicine
b
L1 (~36 hAEL)
L2 (~60 hAEL)
Early L3 (~74 hAEL)
Late L3 (~98 hAEL)
HmlΔRFP/+
R
F
P
c HmlΔRFP/+ 30 h after wasp infestation
R
F
P
Early L3
d
0
10,0
N
u
m
b
e
r 
o
f
s
e
s
s
il
e
 p
o
c
k
e
ts
 /
 h
e
m
i-
la
rv
a
n>11
7,5
5,0
2,5
C
on
tro
l
A
fte
r w
as
p
in
fe
st
at
io
n
***
e
48 h after wasp infestation
(Late L3)
Melanotic tumor gcm>gtrace-LacZ
P
h
a
ll
o
id
in
 /
 S
rp
 /
 L
a
c
Z
f
P
h
a
ll
o
id
in
 /
 S
rp
 /
 L
a
c
Z
Hemocytes gcm>gtrace-LacZ (n=3 with at least 10 larvae per replicate)
2 h after wasp infestation
24 h after wasp infestation
72 h after wasp infestation
L2
(2 h after wasp infestation)
LacZ+ hemocytes: 100 % (53/53)
Lamellocytes: 0%
Early L3
(24 h after wasp infestation)
LacZ+ hemocytes: 100 % (392/392)
Lamellocytes: 48.8% +/- 1.5
Wandering L3
(72 h after wasp infestation)
LacZ+ hemocytes: 10.4 % (516/516)
Lamellocytes: 7.8% +/- 2.7
24 hAEL 48 hAEL 72 hAEL 96 hAEL 120 hAEL
L1 L2
Early
L3
Wandering
L3
Late
L3
Wasp
infestation
a
72 h after wasp infestation
(Wandering L3)
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Figure 9 continued on next page
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positive) (Figure 9e). Tumor melanization (Figure 8—figure supplement 1d,d’) hampers proper
immunolabelling and quantification of these cells, but clearly their contribution becomes very limited
in tumors at later stages (Wandering L3), which are almost completely made of cells from the lymph
gland (Srp positive, LacZ negative).
We finally gtraced the embryonic hemocytes (circulating + sessile) and found that they are all of
embryonic origin in L2 (2 hr after infestation) (Figure 9f). No lamellocyte can be observed by this
stage. The hemocytes are all of embryonic origin by Early L3 as well (24 hr after infestation), but by
this stage they start to differentiate into lamellocytes (48.8% express a lamellocyte identity). By con-
trast, most of the circulating hemocytes come from the lymph gland by Wandering L3 (72 hr after
infestation), as only 10.4% are of embryonic origin, suggesting that the lymph glands histolyzed. At
this stage, fewer lamellocytes are in circulation (7.8%), likely because they are recruited to the
tumors that appear in late L3.
Altogether, the developmental and lineage analyses strongly suggest that the sessile hemocytes
are mobilized in response to the wasp infestation and start forming the melanotic tumors, to which
the hemocytes of the lymph gland contribute at later stages (Figure 10).
Discussion
Immune cells play a key role in physiology and in pathology, therefore understanding how the differ-
ent hematopoietic waves work is of fundamental importance in basic and medical science. We here
show that the embryonic Drosophila hemocytes represent major mediators of the immune response
by transducing signals that eventually affect the larval hematopoietic organ, the lymph gland. A cru-
cial player of the underlying cellular network is the Gcm transcription factor, which is specifically
expressed in the embryonic hemocytes and modulates the response to chronic and acute challenges.
This transiently expressed factor does so by, at least in part, regulating the expression of inhibitors
of the Jak/Stat pathway. The activation of this pathway in the embryonic hemocytes induces the
overproduction of Upd2 and Upd3, two pro-inflammatory cytokines that in turn activate the Jak/Stat
pathway in the muscles and the precocious histolysis of the lymph gland. In sum, a molecular cas-
cade specific to the first hematopoietic wave has long-lasting effects that modulate the second wave
and the inflammatory response.
Impact of a developmental cascade on the function of the embryonic
hemocytes
Gcm has been defined as a pioneer transcription factor (Cattenoz and Giangrande, 2015). Its total
loss triggers embryonic lethality associated with the reduction of hemocytes’ number and the almost
complete lack of glial cells (Bernardoni et al., 1997; Lebestky et al., 2000; Alfonso and Jones,
2002; Vincent et al., 1996; Hosoya et al., 1995; Jones et al., 1995). Using genetic backgrounds
that trigger a partial loss of Gcm we could bypass the early defects and reveal its requirement in the
immune response (this paper) and in glial migration (Gupta et al., 2016), showing that pioneer fac-
tors have a much broader spectrum of activities than expected. The late functions (glial migration,
Figure 9 continued
(Makhijani et al., 2011). The larvae display an accumulation of hemocytes in the sessile pockets from the L2 stage
onward. Upon wasp infestation, the sessile hemocytes are released into circulation. Scale bar: 200 mm. (d) Number
of sessile pockets per Late L3 larva (one lateral view per larva = hemi larva) in normal conditions and after wasp
infestation. Each hemi-larva is represented by a dot, the bar represents the average and the error-bars s.e.m.,
n > 11, p-value measured using student test after variance analysis. (e) Representative examples of melanotic
tumors at different stages. Immunolabelling of tumors from gcm> gtrace LacZ larvae, 48 hr and 72 hr after wasp
infestation. Phalloidin (green), Srp (red) and LacZ (white). Left panels show the merged channels, mid panels show
LacZ and Srp labelling and the right panels show LacZ labelling alone. Scale bar: 100 mm. (f) Immunolabelling of
gcm> gtrace LacZ larval hemocytes 2 hr, 24 hr and 72 hr after wasp infestation. Phalloidin (green), Srp (red) and
LacZ (white). The left panels show the merged channels, the mid panels show LacZ labelling alone and the right
panels show Srp labelling alone. Lamellocytes can be recognized by the strong expression of Phalloidin and by
their very large size. Scale bar: 50 mm.
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hemocyte response to inflammation) require lower levels of Gcm than the early functions (glial and
hemocyte differentiation), therefore the potential of this transcription actor depends on the cellular
context. Interestingly, the late functions seem associated with a modulatory role. In glial migration,
Gcm affects the timely initiation of migration and in the immune response as well, Gcm works as a
modulator rather than an instructive factor. Typically, downregulating Gcm does not on its own trig-
ger overt signs of inflammation (hemocyte mobilization, lamellocyte differentiation, melanotic
tumors or precociously histolyzed lymph glands).
Gcm allows the proper development of hemocytes that are later able to respond to chronic or
acute challenges. Such developmental role fits with the early and transient expression of Gcm in the
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Figure 10. Wasp infestation recruits first the embryonic hemocytes and then the LG hemocytes. Timeline
summarizing the sequence of events occurring in the immune system of the larva in normal conditions (top panel)
and upon wasp infestation (lower panel). In normal conditions, only embryonic hemocytes (in red) are present in
the hemolymph until the pupal stage. They start to colonize the sessile pockets by L2 and continue to do so
during L3. The lymph gland (in blue) histolyzes at the beginning of pupal stage to release plasmatocytes into
circulation. Upon wasp infestation (occurring at L2 stage), the sessile hemocytes are mobilized, embryonic
plasmatocytes differentiate into lamellocytes (rhomboid shaped cells) and tumors start forming at Late L3 upon
aggregation of the embryonic hemocytes. The lymph gland histolyzes precociously, to release plasmatocytes and
lamellocytes that contribute to tumor formation in Wandering L3. Plasmatocytes and lamellocytes originating from
the embryo are indicated in red, the ones from the lymph gland in blue. Lamellocytes originating from the embryo
are indicated in red, the ones from the lymph gland are in blue.
DOI: https://doi.org/10.7554/eLife.34890.019
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hemocyte lineages together with the instability of its transcript and product (Cattenoz and Gian-
grande, 2015). Gcm negatively controls the Jak/Stat pathway upon inducing the expression of the
Ptp61F and Socs36E inhibitors in the embryonic hemocytes. We provide several lines of evidence for
Jak/Stat pathway inhibition by Gcm to have long-lasting effects. First, over-activating the Jak/Stat
pathway specifically in the embryonic hemocytes triggers the formation of melanotic tumors and
precocious lymph gland histolysis. Second, silencing Gcm or activating the Jak/Stat pathway in the
embryonic hemocytes triggers the overproduction of pro-inflammatory Upd cytokines that act non-
autonomously and trigger both tumor formation and precocious lymph gland histolysis. Third, Gcm
downregulation triggers the sustained expression of those cytokines in the larval hemocytes, likely
through Jak/Stat auto- and cross-regulation. The fact that Gcm expression is not under the control
of the immune challenge (Jak/Stat over-activation or wasp infestation) also supports the hypothesis
that the observed phenotypes are due to a developmental defect.
Additional factors likely contribute to the long-lasting effects of modulating Gcm expression in
the embryo. In addition, the DamID screen identified Gcm direct targets that are required late in
hematopoiesis and/or in hemocyte functions, such as phagocytosis, autophagy and defense
response to fungi and Gram-negative bacteria (Cattenoz et al., 2016). Thus, Gcm may also directly
impact late events in the immune system, as is the case in the nervous system where it induces
threshold expression levels of a chemoattractant receptor that promotes glial migration
(Gupta et al., 2016).
Finally, the exacerbated response to acute or chronic challenges due to the low levels of Gcm in
the embryonic hemocytes indicate that active repression of the pro-inflammatory Jak/Stat pathway
may be required to ensure a fast and efficient response upon challenges.
The finding that altering the expression levels of a developmental factor triggers an inflammatory
response that is too strong or too weak, which are both detrimental conditions, constitutes an addi-
tional level of control and opens novel perspectives for understanding the molecular mechanisms
that modulate the inflammatory response in humans as well. This is particularly exciting in view of
recent findings showing that prenatal inflammation and altered development of microglia, the
immune cells of the brain, affect the postnatal function of the brain (Thion and Garel, 2017).
Interaction between gcm and the jak/Stat pathway
The role of Gcm is to prevent a state of chronic inflammation induced by the Jak/Stat pathway. Gcm
controls the ‘inflammatory competence’ at least in part by inducing the expression of Ptp61F,
Socs36E and Socs44A, which inhibit the Jak/Stat pathway. In so doing, Gcm prevents the production
of the Upd2 and Upd3 pro-inflammatory cytokines, whose over-expression is sufficient to induce the
inflammatory response (Figure 11). Gcm also directly interacts with dPIAS (Jacques et al., 2009),
which targets Stat92E for degradation via SUMOylation (Kotaja et al., 2002) and dPIAS induces
melanotic tumors when mutated, due to Stat92E constitutive activation (Betz et al., 2001;
Hari et al., 2001). Thus, Gcm can inhibit the Jak/Stat pathway at least in two ways, by regulating the
transcription of the inhibitors, and, in cells in which the Jak/Stat pathway is activated, by binding
dPIAS, which in turn inhibits the transcriptional activity of phosphorylated Stat92E.
Despite the multiple levels of regulation, Gcm does not affect all the processes that depend on
the Jak/Stat pathway, nor do all the Gcm dependent phenotypes seem to rely on the Jak/Stat path-
way: on the one hand, silencing Gcm expression has modest impact on the hemocyte proliferation
observed in hopTum-l animals. On the other hand, the conditional over-activation of the Jak/Stat
pathway does not affect hemocyte mobilization, whereas silencing Gcm does, likely through the
defective expression of genes required for the attachment of hemocytes to the sessile compartment
such as eater (Anderl et al., 2016). Moreover, Gcm modulates the response to wasp infestation,
which involves the Jak/Stat pathway and additional cascades.
How broad is the modulatory role of Gcm in the inflammatory response will await further investi-
gation, but our findings call for a complex cellular network modulating the immune response
through multiple organs and tissues including at least the embryonic hemocytes, the muscles and
the lymph glands. The future challenge will be to dissect this network and assign specific role to the
different tissues and cell types. This will likely include a major player in the humoral response orches-
trated by the fat body, which also secretes molecules necessary to mobilize the sessile hemocytes
(Vanha-Aho et al., 2015).
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The Gcm transcription factor provides a new key to investigate the basis of the inflammatory
response driven by these complex cellular and molecular interactions. Given the overall evolutionary
conservation of the hematopoietic cascades, Gcm orthologous genes may have similar roles. Inter-
estingly, the sea urchin gcm orthologue is expressed and required for the differentiation of pigment
cells, which function as immune cells (Calestani et al., 2003). Focusing on the murine Gcm ortho-
logue will possibly reveal a conserved function in immune/inflammatory responses in higher organ-
isms as well.
Role of the embryonic hemocytes in the inflammatory response
Previous studies have shown that circulating hemocytes play a central role in the inflammatory
responses induced by the fat body (Pastor-Pareja et al., 2008; Vanha-Aho et al., 2015;
Schmid et al., 2014) and by the somatic muscles (Yang et al., 2015). These circulating hemocytes
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Figure 11. Schematic model on the molecular cascade leading to tumor formation upon Jak/Stat activation in the
embryonic hemocytes. (a) gcm> hopTum-l activates the Jak/Stat pathway exclusively in the hemocytes at embryonic
stage. This leads to the production of the Upd2/Upd3 pro-inflammatory cytokines in those cells and to the
activation of the Jak/Stat pathway in the larval muscles. This ultimately results in the formation of melanotic tumors
and in lymph gland histolysis. When gcm> hopTum-l is combined with gcm KD (b), the levels of the inhibitors of the
Jak/Stat pathway controlled by Gcm (i.e. Ptp61F, Socs36E and Socs44A) decrease in the embryonic hemocytes.
This leads to a stronger activation of the Jak/Stat pathway in embryonic hemocytes, which enhances the
production of Upd2/Upd3 and the activation of the Jak/Stat pathway in the muscles. As a consequence,
gcm> hopTum-l, gcm KD animals display stronger phenotypes in terms of lymph gland histolysis and melanotic
tumors.
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comprise hemocytes of embryonic origin and hemocyte released from the lymph gland upon
immune challenges. The use of gcmGal4 and srp(hemo)Gal4 drivers allowed us to dissect the role
and the regulation occurring specifically in the embryonic hemocytes. These cells likely represent the
earliest cellular target upon wasp infestation (extending on data from [Ma´rkus et al., 2009;
Zettervall et al., 2004]), in a sequence of events that include the mobilization of resident hemo-
cytes, the formation of tumors and the histolysis of the lymph gland. Together with the finding that
gcm KD leads to the production of hemocytes that respond much more strongly to inflammatory
cues, this demonstrates that an adequate immune response relies on signaling from the embryonic
to the larval hematopoietic wave (Figure 11).
Embryonic hemocytes may play a primordial role by initiating the inflammatory response, which
alerts all the tissues including the larval hematopoietic organs: this was observed by expressing hop-
Tum-l in embryonic hemocytes and noticing the impact on the somatic muscles and the lymph gland.
They can also act as transducers of the inflammatory signals between the different organs through
the production of the pro-inflammatory cytokines, as knocking down the cytokines in the embryonic
hemocytes strongly decreases the systemic inflammation induced by the hopTum-l mutation.
In sum, the present work reveals the homeostatic interactions between hematopoietic waves,
which ensure an appropriate inflammatory response to acute or chronic challenges. Given that differ-
ent hematopoietic waves give rise to immune cells that coexist and are endowed with specific prop-
erties in vertebrates, it will be interesting to assess whether similar homeostatic interactions take
place in higher organisms.
Materials and methods
Key resources table
Designation Source or reference Identifiers Additional information
Mouse anti-L4 Pr. I. Ando Mouse anti-L4 (1/30)
Rabbit anti-PH3 Upstate biotechnology #06–570 Rabbit anti-PH3 (1/1000)
Mouse anti-Hemese Pr. I. Ando Mouse anti-Hemese (1/30)
Chicken anti-GFP abcam #13970 Chicken anti-GFP (1/500)
Rabbit anti-Serpent Trebuchet, unpublished Rabbit anti-Serpent (1/1000)
Rabbit anti-Stat92E Dr. D. Montell Rabbit anti-Stat92E (1/100)
Rabbit anti-PPO1 Dr. WJ. Lee Rabbit anti-PPO1 (1/100)
Rabbit anti-RFP abcam #62341 Rabbit anti-RFP (1/500)
S2 cells ATCC Ref: CRL-1963 S2 ATCC
Effectene
Transfection Reagent
Qiagen Effectene Transfection
Reagent
WT Bloomington #5905 w1118
hopTum-l Bloomington #8492 hopTum-l/FM7c Point mutation that
constitutively activates
the Jak/Stat pathway
HmlDRFP Makhijani et al., 2011 HmlDRFP
UAS-hopTum-l Harrison et al., 1995 UAS-hopTum-l/CyO,
twilacZ
Reporter line for hop
Tum-l over-expression
Gcm> GFP Soustelle and Giangrande, 2007 gcmGal4,UAS-mCD8
GFP/CyO,Tb
Driver specific to embryonic
hemocytes and glia, gcm
hypomorphic mutation
Gcm KD Bloomington #31519 UAS-gcmRNAi dsRNA reporter line
for gcm down-regulation
Continued on next page
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Continued
Designation Source or reference Identifiers Additional information
Gcm GOF Bernardoni et al., 1997 UAS-gcmF18A Reporter line for gcm
over-expression
Gcm26 Vincent et al., 1996 gcm26/CyOactinGFP Null gcm mutation
Upd2D Bloomington #55727 upd2D 4.7 kb deletion
Upd3D Bloomington #55728 upd3D Imprecise excision
Upd2 KD Bloomington #33988 UAS-upd2RNAi dsRNA reporter line
for upd2 down-regulation
Upd3 KD Bloomington #32859 UAS-upd3RNAi dsRNA reporter line
for upd3 down-regulation
Upd2 GOF Jiang et al., 2009 UAS-upd2/CyO Reporter line for upd2
over-expression
Upd3 GOF Jiang et al., 2009 UAS-upd3/CyO Reporter line for upd3
over-expression
Ptp61F KD Bloomington #32426 UAS-Ptp61FRNAi dsRNA reporter line for
Ptp61F down-regulation
Socs36E KD Bloomington #35036 UAS-Socs36ERNAi dsRNA reporter line for
Socs36E down-regulation
Socs44A KD Bloomington #42830 UAS-Socs44ARNAi dsRNA reporter line for
Socs44A down-regulation
Ptp61Fa GOF Mu¨ller et al., 2005 UAS-Ptp61Fa/CyO Reporter line to over-express
the cytoplasmic splicing
isoform
Ptp61Fc GOF Mu¨ller et al., 2005 UAS-Ptp61Fc/TM3 Reporter line to over-express
the nuclear splicing isoform
Gcm(hemo)> Cattenoz et al., 2016 gcmGal4,UAS-mCD8GFP,
repoGal80/CyO
gcm driver not expressed
in glia, hypomorphic mutation
sn> Zanet et al., 2012 snGal4 Singed driver, specific to
embryonic hemocytes
srp(hemo)> Bru¨ckner et al., 2004 srp(hemo)Gal4 Serpent driver specific to
embryonic hemocytes
dot> Bloomington #67608 DotGal4 Dorothy driver specifically
expressed in embryonic and
larval lymph gland
lz> GFP Bloomington #6314 lzGal4,UAS-mCD8GFP Lozenge driver expressed
in crystal cells
10xStat92E-GFP Bloomington #26198 10xStat92E-GFP Reporter line for STAT activity,
10 Stat92E binding sites
driving GFP expression
Gtrace Bloomington #28282 UAS-FLP;;Ubi-p63E
(FRT.STOP)Stinger
This line allows the analysis
of lineage-traced expression
of Gal4 drivers
Ubi> Bloomington #32551 UbiGal4 Expresses GAL4 in all cells
Continued on next page
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Continued
Designation Source or reference Identifiers Additional information
RFP Bloomington #30556 UAS-RFP Inserted on the second
chromosome
Gtrace-LacZ Bloomington #6355 P{Act5C> polyA>
lacZ.nls1}3
Fiji Schindelin et al., 2012 Fiji
pPac-gcm Miller et al., 1998 pPac-gcm
repoGFP Laneve et al., 2013 4.3 kb repo-GFP
pUAS-hopTum-l Harrison et al., 1995 pUAS-hopTum-l
pUAS-gcmRNAi Vienna Drosophila
Resource Center
(VDRC) #dna1452
pUAS-gcmRNAi
Fly strains and genetics
Flies were raised on standard media at 25˚C. The strains and crosses are detailed in Supplementary
Methods.
In all the figures, the larvae were staged as follow: We selected Wandering L3 that never went
back to the food, were still very mobile and did not show spiracle eversion (this corresponds to a rel-
atively narrow window around ~112 hAEL). At this stage, 6–8 hr are required for pupariation to
occur. All other staging (L1, L2, Early L3, Late L3) were done relative to the time of egg laying:
L1:~36 hAEL; L2:~60 hAEL; Early L3:~74 hAEL; Late L3:~98 hAEL). The stages of L2 and Early L3
were further distinguished by observing the morphology of the anterior spiracles as previously
described (Guha and Kornberg, 2005).
Penetrance and expressivity of melanotic tumors
Tumor penetrance was determined by assessing the percentage of 3rd instar larvae carrying one or
more tumors. To assess the expressivity of the phenotype, we classified the tumors into three cate-
gories according to their size: Small (S), Medium (M) and Large (L) (Mu¨ller et al., 2005). A tumor
was considered as small when a tiny melanotic mass was documented (Figure 1—figure supple-
ment 4d, left panel), as medium, when the melanotic mass covered ¼ the distance between the
borders of a segment (Figure 1—figure supplement 4d, mid panel) and as large when the mela-
notic spot covered ½ the distance between the borders of a segment (Figure 1—figure supplement
4d, right panel). The expressivity of the melanotic tumor phenotype represents the percentage of
small, medium and large tumors counted in each genotype. The p-values were estimated using the
chi-squared test for frequency comparisons between two populations.
Hemocyte counting
Ten third instar larvae were washed in Ringer’s solution (pH 7.3–7.4) containing 0.12 g/L of CaCl2,
0.105 g/L KCl, and 2.25 g/L NaCl, then dried, and bled in a 96-well U-shaped microtiter plate con-
taining 50 mL of Schneider medium complemented with 10% Fetal Calf Serum (FCS), 0.5% penicillin,
0.5% streptomycin (PS), and few crystals of N-phenylthiourea 98% (PTU) (Sigma-Aldrich P7629) to
prevent hemocyte melanization (Lerner and Fitzpatrick, 1950). For circulating hemocyte collection,
the hemolymph was gently allowed to exit, and the total volume was transferred onto a hemocytom-
eter, where the total number of cells were counted, multiplied by the original volume (50 mL) and
the average number of hemocytes per larva was calculated as described in (Kacsoh and Schlenke,
2012). For sessile hemocyte collection, the hemolymph containing the circulating hemocytes was
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transferred to a first well, while sessile hemocytes were scraped and/or jabbed off the carcass in a
second well as described in (Petraki et al., 2015) and counted as above. Each counting was carried
out at least in triplicates. The p-values were estimated after variance analysis using bilateral student
test (see statistics section).
Hemocyte immunolabelling
Ten third instar larvae were treated as stated above and bled in a 96-well U-shaped microtiter plate
containing 200 mL of Schneider medium. Circulating and sessile hemocytes were collected as indi-
cated above and transferred onto a slide using the Cyto-Tek 4325 Centrifuge (Miles Scientific). Sam-
ples were then fixed for 10 min in 4% paraformaldehyde/PBS at room temperature (RT), incubated
with blocking reagent (Roche) for 1 hr at RT, incubated overnight at 4˚C with primary antibodies
diluted in blocking reagent, washed three times for 10 min with PTX (PBS, 0.3% triton-x100), incu-
bated for 2 hr with secondary antibodies, washed twice for 10 min with PTX, incubated for 20 min
with DAPI to label nuclei (Sigma-Aldrich) (diluted to 10 3 g/L in blocking reagent), and then
mounted in Vectashield (Vector Laboratories). The slides were analyzed by confocal microscopy (see
section below on confocal imaging). The following combination of primary antibodies was used to
determine the fraction of lamellocytes: rabbit anti-Serpent (1/1000) (Tre´buchet, unpublished results)
was used to label hemocytes. Serpent is expressed in all hemocyte precursors and is required for the
development of plasmatocytes and crystal cells (Lebestky et al., 2003). Mouse anti-L4 (1/30) was
kindly provided by I. Ando, L4 is an early lamellocyte marker expressed after immune stimulation
(Honti et al., 2010). The fraction of lamellocytes was determined by counting the number of L4/
DAPI positive cells out of the total population of hemocytes present in six confocal fields of vision at
40X magnification and based on Z-series projections. The following combination of primary antibod-
ies was used to determine the fraction of dividing blood cells: rabbit anti-PH3 (1/1000) (Upstate bio-
technology #06–570), to assess the mitotic activity, and mouse anti-Hemese (1/30), kindly provided
by I. Ando, which recognizes a glycosylated transmembrane protein belonging to the sialophorin
protein family and expressed in all larval hemocytes (Kurucz et al., 2003). The fraction of dividing
cells was determined by counting the number of PH3/Hemese/DAPI positive cells out of the total
population of hemocytes, as above. The following combination of primary antibodies was used to
determine the fraction of crystal cells: rabbit anti-Serpent (1/1000) and chicken anti-GFP (1/500)
(abcam #13970), directed against the membrane GFP signal in lzGal4,UAS-mCD8GFP driver
expressed in crystal cells. The fraction of crystal cells was determined by counting the number of
GFP/Srp/DAPI positive cells out of the total population of hemocytes, as above. Secondary antibod-
ies were: donkey anti-rabbit coupled with Cy3 (1/600) (Jackson #711-165-152), donkey anti-mouse
coupled with Cy3 (1/600) (Jackson #715-165-151), goat anti-mouse coupled with FITC (1/400) (Jack-
son #115-095-166), goat anti-mouse coupled with Alexa Fluor 647 (1/400) (Jackson #115-175-100)
and goat anti-rabbit coupled with Alexa Fluor 647 (1/400) (Jackson #711-175-144). Each immunolab-
elling was carried out on three independent trials. The p-values were estimated after variance analy-
sis using bilateral student test.
Crystal cell quantification on larval cuticle
Six 3rd instar larvae were washed in 1X PBS and heated at 70˚C for 10 min in 500 mL of 1X PBS. This
procedure leads to the activation of prophenoloxidases (PPOs) within the crystal cells and as a result,
these cells appear as black superficial spots on the larval cuticle (Binggeli et al., 2014; Rizki et al.,
1980). 3rd instar larval lateral view images were taken under the fluorescent macroscope (Leica, Z16
APO) to cover parts of the dorsal and ventral sides, and superficial crystal cells were counted as
described in (Bretscher et al., 2015). The p-values were estimated after variance analysis using bilat-
eral student test.
Cell line
S2 Drosophila cells from ATCC Ref: CRL-1963 were used. The identity has been athenticated (STR
profiling). No mycoplasm contamination.
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Transfection and qPCR in Drosophila S2 cells
Six million (6E6) Drosophila S2 cells were plated per well in a 6-well plate with 1.5 mL of Schneider
medium +10% FCS+0.5% PS. Transfections were carried out 12 hr after plating, using the Effectene
Transfection Reagent (Qiagen) as described in (Cattenoz et al., 2016). These transfection assays
were used to assess the transactivation potential of (i) Gcm, (ii) HopTum-1, (iii) the impact of Gcm on
Stat92E localization and (iv) to assess the gcm RNAi efficiency.
i. To determine the role of Gcm in inducing Ptp61F, Socs36E, Socs44A, Upd2 and Upd3
expression, 2 mg of pPac-gcm expression vector (Miller et al., 1998) was transfected with 1
mg of 4.3 kb repo-GFP (repoGFP) (Laneve et al., 2013): Gcm induces the expression of its
target repo and drives the expression of GFP, allowing us to recognize and sort the trans-
fected cells (Laneve et al., 2013). Co-transfection of 2 mg of pPac-gal4 driver plasmid and 1
mg of pUAS-GFP reporter plasmid was performed as a negative control (Figures 2e and 4g).
ii. To determine the role of hopTum-l in inducing Upd2 and Upd3 expression, 0.5 mg of pPac-
gal4 plasmid, 0.5 mg of pUAS-GFP and 0.5 mg of pUAS-hopTum-l reporters were co-trans-
fected (Harrison et al., 1995). Co-transfection of 0.5 mg of pPac-gal4 driver plasmid and 0.5
mg of pUAS-GFP, and 0.5 mg of pUAS-Empty was performed as a negative control
(Figure 4g).
iii. To assess the impact of Gcm on Stat92E localization/expression, S2 cells were transfected as
described above with 0.5 mg pPac-gal4 and 0.5 mg pUAS-RFP (Control), or 0.5 mg pPac-gal4,
0.5 mg pUAS-RFP and 0.5 mg pUAS- hopTum-l (hopTum-l GOF), or 0.5 mg pPac-gal4, 0.5 mg
pUAS-RFP, 0.5 mg pUAS- hopTum-l and 0.5 mg pPac-gcm (hopTum-l GOF, gcm GOF). 48 hr
after transfection, the cells were immunolabelled with rabbit anti-Stat92E (1/100, kindly pro-
vided by Dr. D. Montell [Jang et al., 2009]) and rat anti-RFP (1/500, Chromotek #5F8) as
described for the hemocytes (Figure 2a–c).
iv. To assess the gcm RNAi efficiency, S2 cells were transfected as described above with 0.25
mg pPac-gal4 driver, 0.25 mg of pUAS-gcm expression vector, 0.25 mg of 4.3 kb repo-GFP
(repoGFP) (Laneve et al., 2013), 0.25 mg of pUAS-RFP reporter and 0.25 mg of pUAS-
gcmRNAi vector (Vienna Drosophila Resource Center (VDRC) #dna1452, used to build the
UAS-gcmRNAi strain Bloomington #31519). The controls were S2 cells transfected with the
same set of plasmids except for pUAS-gcm or pUAS-gcmRNAi that were replaced by pUAS-
Empty vector. The levels of GFP and RFP were analyzed 48 hr after transfection using FACS-
Calibur. The GFP levels were measured in RFP positive cells (Figure 1—figure supplement
3a).
For the transfection assays, each combination of plasmids was mixed in 90 mL of EC buffer and 8
mL of enhancer per mg of plasmid followed by 5 min incubation at RT. 25 mL of Effectene was then
added and the mix was incubated at RT for 20 min. Then, 500 mL of Schneider medium +10% FCS
+0.5% PS was added to the mix followed by spreading it on the cells. For (i) and (ii), plates were
then incubated at 25˚C for 48 hr followed by sorting on a BD FACSAria, according to GFP or RFP
expression to obtain more than 80% of transfected cells in the sample (Cattenoz et al., 2016). RNA
was then extracted using TRI reagent (Sigma-Aldrich), 1 mg was treated by DNAse1 (RNAse-free)
(Thermo Fisher Scientific) and reverse transcribed with Superscript II (Invitrogen). Quantitative PCR
(qPCR) assays were performed on a lightcycler LC480 (Roche) with SYBR master (Roche) on the
equivalent of 5 ng of reverse transcribed RNA with the primer pairs targeting Ptp61F, Socs36E,
Socs44A, upd2 and upd3 listed in supplementary methods. Each PCR was carried out in at least
three independent replicates. The quantity of each transcript was normalized to the levels of tran-
scripts of two different housekeeping genes, Glyceraldehyde-3-phosphate-dehydrogenase-1
(Gapdh1) and Actin-5c (Act5c). The p-values were estimated after comparing control to transfected
cells using bilateral student test.
Larval and embryonic hemocyte RNA extraction and qPCR
For embryonic hemocytes, stage 16 embryos carrying srp(hemo)> RFP (see supplementary meth-
ods) were dissociated in PBS using a Dounce homogenizer on ice. The RFP positive cells were then
sorted after filtration on a 70 mm filter on a BD FACSAria. At least 10,000 RFP positive cells were
used per replicate. For the larval hemocytes, thirty 3rd instar larvae were bled in a 96-well U-shaped
microtiter plate containing 200 mL of Schneider medium to collect circulating hemocytes as stated
above. Cells were centrifuged at 3000 rpm for 10 min at 4˚C. RNA was then extracted using TRI
reagent and Quantitative PCR (qPCR) assays were performed on a lightcycler LC480 as stated above
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with the primer pairs listed in supplementary methods targeting plasmatocytes markers
(Stofanko et al., 2010): crq, Hml, lectin-24A, eater, He and NimC1; lamellocyte markers: Filamin-
240 (cher), a-PS5 (ItgaPS5), mys, bInt-n (Itgbn), Tep1, Tep4 and PPO3; crystal cell markers: lz, hnt
(peb) and PPO1; pro-inflammatory cytokines: upd2 and upd3. Each PCR was carried out in at least
three independent replicates. The p-values were estimated after comparing control to transfected
cells using bilateral student test (see below).
Lymph gland immunolabelling
Lymph glands from 3rd instar wandering larvae (6 h-8h before pupariation) were dissected in Ringer’s
solution (pH 7.3–7.4), fixed for 30 min in 4% paraformaldehyde/PBS at 4˚C, washed three times for
10 min with PTX, incubated with blocking reagent for 1 hr at 4˚C, incubated overnight at 4˚C with
primary antibodies, washed three times for 10 min with PTX, incubated for 1 hr with secondary anti-
bodies, washed two times for 10 min with PTX, incubated for 20 min with DAPI and then mounted
on slides in Vectashield. The slides were analyzed by confocal microscopy (see below). The primary
antibody was the mouse anti-L4 (1/30). The secondary antibody was the goat anti-mouse coupled
with FITC (1/400) (Jackson #115-095-166). The percentage of precociously histolyzed and lamello-
cyte expressing lymph glands was assessed. Note that in genotypes carrying the hopTum-l systemic
mutation most lymph glands lose their integrity and display only part of the primary and/or second-
ary lobes because the tissue undergoes precocious histolysis.
Embryo immunolabelling
Drosophila embryos from overnight egg laying at 25˚C on apple agar plates were collected, treated
and immunolabelled as described in (Vincent et al., 1996). They were dechorionated in bleach,
rinsed in water then fixed in a solution containing 1 vol. of heptane and 1 vol. of 4% paraformalde-
hyde in PBS 1x for 25 min. Next, they were devitellinized in methanol and heptane for 1 min fol-
lowed by treatment with PTX and incubation in blocking reagent for 1 hr at RT. Then, embryos were
incubated overnight at 4˚C with primary antibodies, washed three times for 10 min with PTX, incu-
bated for 2 hr with secondary antibodies, washed two times for 10 min with PTX, incubated for 20
min with DAPI and then mounted on slides in Vectashield. The slides were analyzed by confocal
microscopy (see section below). The following combination of primary antibodies was used to label
crystal cells: rabbit anti-PPO1 (1/100) was kindly provided by WJ. Lee. PPOs are essential enzymes in
the melanization process, where PPO1 is crystal cell specific marker (Binggeli et al., 2014;
Nam et al., 2012). Chicken anti-GFP (1/500) (abcam #13970) was used to select for right genotype
embryos based on CyOactinGFP expression. Rabbit anti-RFP (1/500) (abcam #62341) was directed
against the RFP signal driven by lzGal4 driver expressed in crystal cells. Secondary antibodies used
were: donkey anti-rabbit coupled with Cy3 (1/600) (Jackson #711-165-152) and donkey anti-chicken
coupled with FITC (1/400) (Jackson #703-095-155).
Jak/Stat expression and activity in larval somatic muscles
Activation of the Jak/Stat pathway was observed in the muscles using the 10xStat92E-GFP reporter
as indicated in (Yang et al., 2015). The larvae were frozen and mounted between two slides in
water. The images of the larvae were taken at the fluorescent macroscope (Leica, Z16 APO) using
10X magnification and 500 ms of exposure time. The contrast and luminosity of each image were
adjusted using Fiji (Schindelin et al., 2012); the same correction was applied to all conditions.
In a second approach, Stat92E was directly labelled in striated muscles. Larvae were prepared
using the same approach than for the lymph gland described above and labelled with Phalloidin cou-
pled with FITC (1/200), rabbit anti-Stat92E (1/100, kindly provided by Dr. D. Montell [Jang et al.,
2009]) and DAPI. The images were acquired with Leica SP5 inverted-based confocal microscope
using hybrid detectors in photon counting mode and analyzed using the measurement plugin from
the software Fiji (Schindelin et al., 2012). For total Stat92E quantification, areas covering the muscle
on single confocal plans were selected and the absolute intensity/area(mm2) of Stat92E signal were
calculated for at least 20 muscles in three animals per genotype. To calculate the ratio nuclear/cyto-
plasmic, Stat92E levels were measured in each nucleus individually and coupled with the levels in an
area of the same size adjacent to the nucleus. The nuclei were identified using the DAPI signal.
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Wasp survival and encapsulation assays
Wasp parasitization by L. Boulardi is commonly used to study the immune response of Drosophila
(Yang et al., 2015; Small et al., 2012; Vanha-Aho et al., 2015; Kari et al., 2016). The wasp lays
eggs in the Drosophila larva, which induces a strong systemic inflammatory cascade that leads to the
differentiation of plasmatocytes into lamellocytes and to the encapsulation of the wasp egg
(Small et al., 2012). The wasp survival and encapsulation assays were conducted as described in
(Vanha-Aho et al., 2015; Kari et al., 2016) with some modifications.
For wasp survival, 100 first instar Drosophila larvae (~24 hAEL) of the indicated genotypes were
transferred into a fresh vial at 25˚C. At second instar stage (~54 hAEL), 20 couples of L. boulardi
were added into the vial for infestation for 2 hr, then removed. Following this, the number of wasps
hatching from each vial was counted to estimate the % of lethality (1-wasps/Drosophila larvae). The
sessile pocket observation and the gtrace experiment presented in Figure 9 were done with this
infestation protocol.
For the encapsulation assay, Drosophila of the indicated genotypes were allowed to lay eggs for
24 hr at 25˚C. The vials containing the embryos were then transferred to 29˚C until the second instar
stage (48 hr). The Drosophila larvae were then exposed to 10 couples of L. boulardi for 2 hr at 25˚C
and after parasitization the vials were incubated at 29˚C until the third instar stage. Wandering larvae
were dissected to assess the level of melanization of the wasp larvae: total encapsulation (dead
wasp larvae completely melanized), partial encapsulation (living larvae, with some melanization), no
encapsulation (living larvae, no melanization). Only Drosophila larvae containing a single wasp larva
were analyzed.
DamID peaks
The DNA adenine methyltransferase identification (DamID) is an antibody independent method
allowing the identification of loci bound by transcription factors (van Steensel and Henikoff, 2000;
van Steensel et al., 2001). Using this approach, the Gcm binding sites in the Drosophila genome
were recently determined (Cattenoz et al., 2016). The peaks indicating Gcm binding onto the
Ptp61F, Socs36E and Socs44A loci are represented in Figure 1—figure supplement 4g–i using the
University of California Santa Cruz (UCSC) Genome Browser (https://genome.ucsc.edu).
Statistical analysis
The chi-squared test for frequency comparisons between two populations was used to estimate the
p-values between percentages of tumors in 3rd instar larvae and the expressivity of melanotic tumors
in various genotypes tested, where bilateral student test is not applicable. Variance analysis using
bilateral student tests for unpaired samples was used to estimate the p-values in hemocyte counting,
hemocyte immunolabelling and qPCR assays; in each case, at least three independent trials were
performed. In all analyses, ‘ns’ stands for not significant, for p-value> 0.05; ‘*’ for p-value<0.05; ‘**’
for p-value<0.01; ‘***’ for p-value<0.001. All the P values are in Figure 1—source data 1.
Confocal imaging
Leica SP5 inverted-based microscope equipped with 20, 40 and 63X objectives was used to obtain
confocal images. GFP/FITC was excited at 488 nm; the emission filters 498–551 were used to collect
the signal. Cy3 was excited at 568 nm; emission filters 648–701 were used to collect the signal, and
Cy5 was excited at 633 nm; emission signal was collected at 729–800 nm. A step size between 0.2
and 2 mm was used to collect the Z-series of images, which were then treated with Fiji
(Schindelin et al., 2012) to obtain fluorescent images using maximum Z-projections. In all images,
the intensity of the signals was set to the same threshold in order to compare the different
genotypes.
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